Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Inventory (2016 - 2025)

Conmed's Inventory history spans 16 years, with the latest figure at $355.5 million for Q4 2025.

  • For Q4 2025, Inventory rose 2.55% year-over-year to $355.5 million; the TTM value through Dec 2025 reached $355.5 million, up 2.55%, while the annual FY2025 figure was $355.5 million, 2.55% up from the prior year.
  • Inventory reached $355.5 million in Q4 2025 per CNMD's latest filing, down from $364.4 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $364.4 million in Q3 2025 to a low of $205.8 million in Q1 2021.
  • Average Inventory over 5 years is $306.8 million, with a median of $324.1 million recorded in 2023.
  • Peak YoY movement for Inventory: skyrocketed 43.46% in 2022, then decreased 4.21% in 2023.
  • A 5-year view of Inventory shows it stood at $231.6 million in 2021, then soared by 43.46% to $332.3 million in 2022, then fell by 4.21% to $318.3 million in 2023, then increased by 8.92% to $346.7 million in 2024, then increased by 2.55% to $355.5 million in 2025.
  • Per Business Quant, the three most recent readings for CNMD's Inventory are $355.5 million (Q4 2025), $364.4 million (Q3 2025), and $362.3 million (Q2 2025).